Total Funding
47
29
Total FundingPost-IPO Debt raised
Growth Score 47 in past quarter
-36 pts
Heat Score 29 in past quarter
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
180781
Imagion Biosystems is a Biotechnology Company.
Robert Proulx: President & CEO- Yalia Jayalakshmi: Chief Development OfficerPast Role: Onconano Medicine, VP of Clinical Development
About the Company
Imagine the day when cancer can be detected early enough that treatments can be pinpoint targeted, not make you ill, and be highly effective. That’s how we think at Imagion Biosystems, where we aim to reduce the pain, suffering and loss of life caused by cancers by developing a simple non-invasive test with the sensitivity to detect and
characterize tumors in their early stages when they are more treatable.
